Cargando…
Urinary laminin‐γ2 is a novel biomarker of non‐muscle invasive urothelial carcinoma
Lack of appropriate biomarkers has hampered early detection of urothelial cancer (UC), therefore, development of biomarkers for its diagnosis at earlier stages is of importance. Laminin‐332 (Ln‐332, formerly Ln‐5), a component of basement membranes, consists of Ln‐α3, Ln‐β3, and Ln‐γ2 polypeptides....
Autores principales: | Kamada, Masayuki, Koshikawa, Naohiko, Minegishi, Tomoko, Kawada, Chiaki, Karashima, Takashi, Shuin, Taro, Seiki, Motoharu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714663/ https://www.ncbi.nlm.nih.gov/pubmed/26450632 http://dx.doi.org/10.1111/cas.12832 |
Ejemplares similares
-
Development of a fully automated chemiluminescence immunoassay for urine monomeric laminin-γ2 as a promising diagnostic tool of non-muscle invasive bladder cancer
por: Nakagawa, Masatoshi, et al.
Publicado: (2017) -
Clinical evaluation of urine laminin‐γ2 monomer as a potent biomarker for non‐muscle invasive bladder cancer
por: Karashima, Takashi, et al.
Publicado: (2022) -
Specific detection of soluble EphA2 fragments in blood as a new biomarker for pancreatic cancer
por: Koshikawa, Naohiko, et al.
Publicado: (2017) -
Serum monomeric laminin‐γ2 as a novel biomarker for hepatocellular carcinoma
por: Kiyokawa, Hirofumi, et al.
Publicado: (2017) -
Unique Biological Activity and Potential Role of Monomeric Laminin-γ2 as a Novel Biomarker for Hepatocellular Carcinoma: A Review
por: Yasuda, Hiroshi, et al.
Publicado: (2019)